Amicucci Matteo, Biagioli Valentina, Rostagno Elena, Canesi Marta, Bergadano Anna, Botta Debora, Crotti Partel Moreno
Department of Onco Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio Square, 4, 00165, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier, 1, Rome, Italy.
Clin Hematol Int. 2022 Sep;4(3):99-106. doi: 10.1007/s44228-022-00010-w. Epub 2022 Jun 23.
This study aimed to describe and compare, at a national level, the measures implemented in the pediatric onco-hematology units and the number of infections among patients and healthcare staff during the first and second wave of the COVID-19 pandemic in Italy. A multicenter, descriptive, online survey was conducted between15th March and 15th April 2020 (T1) and between 1 and 31st January 2021 (T2). All the Italian Pediatric Oncology and Hematology Association (AIEOP) centers were invited to participate in the study. Data of the pre-pandemic, first, and second phase were compared. Thirty-six of the 48 AIEOP centers completed the survey (75%). Several organizational, screening, and swab measures were implemented by AIEOP centers to prevent the SARS-CoV-2 infection among patients and visitors. During the pandemic, there was a significant reduction in the number of onco-hematology inpatient beds (p < 0.001), including inpatient beds dedicated to hematopoietic stem cell transplantation (HSCT), and consultations in the outpatient clinics (p < 0.001). During the first wave, 37 pediatric patients with cancer tested positive for SARS-CoV-2 versus 174 patients during the second wave. The reduction in routine services was also greater in the second than in the first wave. All the AIEOP centers showed the capacity to adapt and promptly respond to both waves of the pandemic.
本研究旨在描述和比较意大利全国范围内,在新冠疫情第一波和第二波期间,儿科肿瘤血液科所采取的措施以及患者和医护人员的感染数量。于2020年3月15日至4月15日(T1)以及2021年1月1日至31日(T2)开展了一项多中心、描述性在线调查。邀请了意大利所有儿科肿瘤与血液学协会(AIEOP)中心参与该研究。对疫情前、第一阶段和第二阶段的数据进行了比较。48个AIEOP中心中有36个完成了调查(75%)。AIEOP中心实施了多项组织、筛查和拭子检测措施,以预防患者和访客感染SARS-CoV-2。疫情期间,肿瘤血液科住院床位数量显著减少(p < 0.001),包括造血干细胞移植(HSCT)专用住院床位,门诊咨询量也显著减少(p < 0.001)。第一波疫情期间,37名患癌儿科患者的SARS-CoV-2检测呈阳性;第二波疫情期间,这一数字为174名。第二波疫情期间常规服务的减少幅度也大于第一波。所有AIEOP中心均表现出适应能力,并能迅速应对两波疫情。